Advertisement

Journal of Hepato-Biliary-Pancreatic Sciences

, Volume 20, Issue 1, pp 35–46 | Cite as

TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos)

  • Masamichi YokoeEmail author
  • Tadahiro Takada
  • Steven M. Strasberg
  • Joseph S. Solomkin
  • Toshihiko Mayumi
  • Harumi Gomi
  • Henry A. Pitt
  • O. James Garden
  • Seiki Kiriyama
  • Jiro Hata
  • Toshifumi Gabata
  • Masahiro Yoshida
  • Fumihiko Miura
  • Kohji Okamoto
  • Toshio Tsuyuguchi
  • Takao Itoi
  • Yuichi Yamashita
  • Christos Dervenis
  • Angus C. W. Chan
  • Wan-Yee Lau
  • Avinash N. Supe
  • Giulio Belli
  • Serafin C. Hilvano
  • Kui-Hin Liau
  • Myung-Hwan Kim
  • Sun-Whe Kim
  • Chen-Guo Ker
Guideline TG13: Updated Tokyo Guidelines for acute cholangitis and acute cholecystitis

Abstract

Since its publication in 2007, the Tokyo Guidelines for the management of acute cholangitis and cholecystitis (TG07) have been widely adopted. The validation of TG07 conducted in terms of clinical practice has shown that the diagnostic criteria for acute cholecystitis are highly reliable but that the definition of definite diagnosis is ambiguous. Discussion by the Tokyo Guidelines Revision Committee concluded that acute cholecystitis should be suspected when Murphy’s sign, local inflammatory findings in the gallbladder such as right upper quadrant abdominal pain and tenderness, and fever and systemic inflammatory reaction findings detected by blood tests are present but that definite diagnosis of acute cholecystitis can be made only on the basis of the imaging of ultrasonography, computed tomography or scintigraphy (HIDA scan). These proposed diagnostic criteria provided better specificity and accuracy rates than the TG07 diagnostic criteria. As for the severity assessment criteria in TG07, there is evidence that TG07 resulted in clarification of the concept of severe acute cholecystitis. Furthermore, there is evidence that severity assessment in TG07 has led to a reduction in the mean duration of hospital stay. As for the factors used to establish a moderate grade of acute cholecystitis, such as leukocytosis, ALP, old age, diabetes, being male, and delay in admission, no new strong evidence has been detected indicating that a change in the criteria used in TG07 is needed. Therefore, it was judged that the severity assessment criteria of TG07 could be applied in the updated Tokyo Guidelines (TG13) with minor changes. TG13 presents new standards for the diagnosis, severity grading and management of acute cholecystitis.

Free full-text articles and a mobile application of TG13 are available via http://www.jshbps.jp/en/guideline/tg13.html.

Keywords

Acute cholecystitis Diagnostic criteria Severity grading Diagnostic imaging Guidelines 

Introduction

Acute cholecystitis is a disease frequently encountered in daily practice presenting with right hypochondrial pain as the main symptom [1, 2, 3, 4]. However, there were no diagnostic criteria and severity assessment criteria for this commonplace disease before the publication in 2007 of the Tokyo Guidelines for the management of acute cholangitis and cholecystitis (TG07) in the Journal of Hepato-Biliary-Pancreatic Surgery (vol. 14.1:1–121, 2007). There is a treatise in TG07 released with the expectation that it will present international guidelines for improvement in the diagnosis and treatment of acute cholecystitis [5].

The diagnostic criteria in TG07 were set at high sensitivity to provide medical care suitable for a larger number of cases and the sensitivity has been reported as 84.9 % on the basis of the test results for TG07 diagnostic criteria [6]. TG07 guidelines have already been recognized as the diagnostic criteria to be recommended in today’s medical care for acute cholecystitis [1]; however, guidelines should achieve further evolution. In view of the current situation where diagnostic imaging such as ultrasonography (US), CT and scintigraphy (HIDA scan) are frequently used for the definite diagnosis of acute cholecystitis, integration of such diagnostic modalities in guidelines is the main theme in the present revision.

Acute cholecystitis sometimes requires emergency treatment for morbidities such as gangrenous cholecystitis, emphysematous cholecystitis and gallbladder torsion. An indication that it may require high-level skills is given by its other name, “difficult gallbladder” [7, 8]. In making a diagnosis of acalculous cholecystitis, challenges may be encountered. There may be cases with a poor prognosis [9, 10]. The severity assessment criteria in TG07 defined severe acute cholecystitis as acute cholecystitis accompanying organ dysfunction directly related to vital prognosis. Actually, the overall mortality rate of acute cholecystitis is approximately 0.6 % [11, 12], and that of severe cases was reported in TG07 as 6.0 % [13]. Acute cholecystitis is essentially not a disease with a high mortality rate. However, it was thought that guidelines should make it clear that appropriate management with appropriate use of severity assessment criteria does lead to improved vital prognosis.

Six years have passed since the publication of TG07 and the Tokyo Guidelines Revision Committee has been charged with examining the results of the validation that has been conducted so far, involving problems such as inconvenience of their use in actual clinical settings [6, 13, 14, 15]. Considering the progress of diagnostic technology and detection of new evidence, diagnostic criteria and severity grading revised as the updated Tokyo Guidelines (TG13) are presented in accordance with actual clinical settings [16].

Diagnostic criteria for acute cholecystitis; TG13

Background

Murphy’s sign

Q1. How large is the diagnostic capacity of Murphy’s sign for acute cholecystitis?

Murphy’s sign refers to where the patient stops breathing due to pain when an examiner touches the inflammatory gallbladder of the patient. In 1903, Murphy [17] described the condition as a sign of cholelithiasis. Murphy’s sign has also been widely known as a diagnostic factor of acute cholecystitis. Substantial numbers of clinicians throughout the world providing treatment for acute cholecystitis refer to Murphy’s sign. It has been reported in previous studies to have a sensitivity of 50–65 % and a high specificity of 79 % [18] or 96 % [2] for the diagnosis of acute cholecystitis although the sensitivity was once reported to be as low as 20.5 %, while the specificity was 87.5 % [6]. It has a weak point in that an accurate diagnosis of cholecystitis can be made when Murphy’s sign is present, while its absence does not necessarily mean the absence of cholecystitis.

TG07 diagnostic criteria for acute cholecystitis

Q2. How are the diagnostic criteria for acute cholecystitis in TG07 appraised?

At an international consensus meeting held in Tokyo in 2007, the world’s first diagnostic criteria were presented in the Tokyo Guidelines for the management of acute cholangitis and cholecystitis; these are international clinical practice guidelines. According to a review referring to these diagnostic criteria, a definite diagnosis of acute cholecystitis can be made when a local sign or symptom and a systemic sign are present, and test imaging provides confirmation [1]. There is a report of cases for which favorable sensitivity (84.9 %) and specificity (50.0 %) have been achieved when using TG07 diagnostic criteria in clinical practice [6]. Multicenter analysis by the Tokyo Guidelines Revision Committee showed that the sensitivity was 92.1 % and the specificity was 93.3 % in TG07 [16].

Revision of TG07 diagnostic criteria for acute cholecystitis

The most important problem in TG07 was that the criteria for definite diagnosis were ambiguous and difficult to use. In TG07, there were two categories determining the definite diagnosis of acute cholecystitis. “Definite diagnosis 1”: To obtain a definite diagnosis one item in A and one item in B had to be positive. “Definite diagnosis 2”: Imaging findings (criterion C) confirmed the diagnosis when acute cholecystitis was suspected clinically.

The Tokyo Guidelines Revision Committee concluded that the term “definite diagnosis” could not be supported in current practice without positive diagnostic imaging studies. We have now changed the expressions: “suspected” diagnosis is achieved when one item from section A and one item from section B are present. “Definite” diagnosis is achieved when imaging findings characteristic of acute cholecystitis (item C) are also present (one item in A + one item in B + C) [16].

TG13 diagnostic criteria for acute cholecystitis

The revised diagnostic criteria for acute cholecystitis are shown in Table 1.
Table 1

TG13 diagnostic criteria for acute cholecystitis

A. Local signs of inflammation etc.

 (1) Murphy’s sign, (2) RUQ mass/pain/tenderness

B. Systemic signs of inflammation etc.

 (1) Fever, (2) elevated CRP, (3) elevated WBC count

C. Imaging findings

 Imaging findings characteristic of acute cholecystitis

Suspected diagnosis: One item in A + one item in B

Definite diagnosis: One item in A + one item in B + C

Acute hepatitis, other acute abdominal diseases, and chronic cholecystitis should be excluded

RUQ right upper abdominal quadrant, CRP C-reactive protein, WBC white blood cell

A diagnosis of acute cholecystitis is made as follows according to diagnostic criteria. When acute cholecystitis is suspected from clinical signs and results of blood tests, a definite diagnosis is made after it has been confirmed by diagnostic imaging.

Q3. How are the diagnostic criteria for acute cholecystitis in TG13 appraised?

An assessment by multicenter analysis of TG13 diagnostic criteria shows that sensitivity (91.2 %) and specificity (96.9 %) are favorable and that diagnostic capacity is almost the same as that in TG07 [16]. It is pointed out that the diagnostic criteria for acute cholecystitis in TG07 have limitations in that patients with few systemic symptoms tends to be underdiagnosed [1]. There is also a report showing that neither fever nor an elevated white cell count were observed in 16 % of cases with gangrenous cholecystitis or in 28 % of cases with non-gangrenous cholecystitis [8]. It is important that the diagnosis is confirmed repeatedly for cases with suspected cholecystitis.

Clinical context and manifestations

Q4. What is the most important physical manifestation for making a diagnosis of acute cholecystitis?
The main symptom of uncomplicated cholelithiasis is biliary colic caused by the obstruction of the gallbladder neck by stones [1]. The proportion of patients with right hypochondrial pain and epigastric pain combined is 72–93 %. This is followed in frequency by nausea and vomiting. Note that the proportion of patients with fever is not high; that of fever exceeding 38 (°C) is low (about 30 %). Muscular defense is observed in about half of cases; palpable tumors are rare in the right hypochondrial region. Rebound tenderness and stiffness are also rare (Tables 2, 3) [2, 3, 4, 19, 20, 21, 22, 23].
Table 2

Incidence of clinical symptoms of acute cholecystitis

 

n

RUQ pain (%)

Epigastralgia (%)

Nausea (%)

Emesis (%)

Fever (%)

Rebound (%)

Guarding (%)

Rigidity (%)

Mass (%)

Murphy’s sign (%)

Eskelinen [2]

124

56

25

31

60

62 (≥37.1 °C)

48

30

66

16

62

Brewer [19]

26

   

77

30 (≥38 °C)

35

58

3.9

  

Schofield [20]

64

   

83

31 (>37.5 °C)

   

14

 

Staniland [21]

100

38

34

About 80

About 70

 

About 30

About 45

About 10

About 25

 

Halasz [3]

191

93

       

23

 

Johnson [4]

37

70

11

73

62

24

    

62

Singer [22]

40

    

10 (>38.0 °C)

    

65

Adedeji [23]

62

         

48

RUQ right upper abdominal quadrant

Table 3

Diagnostic capability of clinical symptoms for acute cholecystitis

 

No. of studies

No. of patients

Summary LR (95 % CI)

Sensitivity (95 % CI)

Specificity (95 % CI)

Positive

Negative

Anorexia

2

1135

1.1–1.7

0.5–0.9

0.65 (0.57–0.73)

0.50 (0.49–0.51)

Emesis

4

1338

1.5 (1.1–2.1)

0.6 (0.3–0.9)

0.71 (0.65–0.76)

0.53 (0.52–0.55)

Fever

8

1292

1.5 (1.0–2.3)

0.9 (0.8–1.0)

0.35 (0.31–0.38)

0.80 (0.78–0.82)

Guarding

2

1170

1.1–2.8

0.5–1.0

0.45 (0.37–0.54)

0.70 (0.69–0.71)

Murphy’s sign

3

565

2.8 (0.8–8.6)

0.5 (0.2–1.0)

0.65 (0.58–0.71)

0.87 (0.85–0.89)

Nausea

2

669

1.0–1.2

0.6–1.0

0.77 (0.69–0.83)

0.36 (0.34–0.38)

Rebound

4

1381

1.0 (0.6–1.7)

1.0 (0.8–1.4)

0.30 (0.23–0.37)

0.68 (0.67–0.69)

Rectal tenderness

2

1170

0.3–0.7

1.0–1.3

0.08 (0.04–0.14)

0.82 (0.81–0.83)

Rigidity

2

1140

0.50–2.32

1.0–1.2

0.11 (0.06–0.18)

0.87 (0.86–0.87)

RUQ mass

4

408

0.8 (0.5–1.2)

1.0 (0.9–1.1)

0.21 (0.18–0.23)

0.80 (0.75–0.85)

RUQ pain

5

949

1.5 (0.9–2.5)

0.7 (0.3–1.6)

0.81 (0.78–0.85)

0.67 (0.65–0.69)

RUQ tenderness

4

1001

1.6 (1.0–2.5)

0.4 (0.2–1.1)

0.77 (0.73–0.81)

0.54 (0.52–0.56)

Cited from Ref. [18]

RUQ right upper abdominal quadrant, LR likelihood ratio, CI confidence interval

Laboratory data

What is the most important blood test for making a diagnosis of acute cholecystitis?

There are no specific blood tests for making a diagnosis of acute cholecystitis. So, the diagnosis can be made if the following findings are present: general inflammatory findings (abnormal white blood cell count, elevated CRP level), an increase in blood cell count of more than 10000 mm3/dl, an increase in CRP level of more than 3 mg/dl, and a mild increase of serum enzymes in the hepato-biliary-pancreatic system and bilirubin.

The bilirubin level may rise to 4 mg/dl (68 μmol/dl) in the absence of complications [1]. When ultrasonography shows findings that suggest acute cholecystitis and a CRP level exceeding 3 mg/dl, a diagnosis of acute cholecystitis can be made with 97 % sensitivity, 76 % specificity, and 95 % positive predictive value [24].

Imaging findings

Ultrasonography (US)

Q5. Which type of diagnostic imaging method should be used, first of all, for making a diagnosis of acute cholecystitis?

Ultrasonography is the test that should be performed first of all for every case of suspected acute cholecystitis. Even emergency physicians who are not specialists in ultrasonography are able to make a satisfactory diagnosis [25, 26].

In view of its convenience and lack of invasiveness, ultrasonography should be considered the first option among morphological tests for this morbidity.

Q6. How large is the diagnostic capacity of ultrasonography for acute cholecystitis?

A report by Chatziioannou et al. [27] discussing 107 cases of acute cholecystitis in terms of the diagnostic capacity of ultrasonography has found that sensitivity is 50 %, specificity 88 %, PPV 64 %, NPV 80 %, and accuracy 77 %.

On the basis of a meta-analysis of five treatises involving a total of 532 cases, Shea et al. show that the diagnostic capability of ultrasonography for acute cholecystitisis: sensitivity 88 % (95 % CI 0.74–1.00) and specificity 80 % (95 % CI 0.62–0.98) [28]. The diagnostic capacity of ultrasonography for acute cholecystitis is generally thought to be good.

Q7. What are the ultrasonographic imaging findings characteristic of acute cholecystitis?
A diagnosis of acute calculous cholecystitis can be made radiologically when the following findings are present at the same time: thickening of the gallbladder wall (5 mm or greater), pericholecystic fluid, or direct tenderness when the probe is pushed against the gallbladder (ultrasonographic Murphy’s sign) [1]. Other ultrasonographic findings may include gallbladder enlargement, gallbladder stones, debris echo and gas imaging (Fig. 1).
Fig. 1

US images of acute cholecystitis. Gallbladder swelling, wall thickening with hypoechoic layer, massive debris, and stone impaction are demonstrated

However, due to differences among reports in the frequency of the occurrence of individual findings, sensitivity, and specificity, diagnosis should be made after a comprehensive judgment has been made of individual findings [29, 30] (Supplement Table 1).

There are many diagnostic modalities enabling depiction of stones. However, there is a report showing that bile stones could be depicted by ultrasonography in only 13 % of cases (1 of 7 cases). Therefore, the use of other techniques, such as MR cholangiography (MRCP), should be considered depending on conditions [31].

According to a report by Cohan et al. [32] who examined 51 cases that had developed thickening of the gallbladder wall, including 13 cases of acute cholecystitis, a so-called sonolucent layer (hypoechoic layer), referred to as a low-echo zone, within the gallbladder wall showed 8 % sensitivity (95 % CI 0–22.1) and 71.0 % specificity (95 % CI 56.6–85.5). Therefore, it cannot be considered a good diagnostic measure for acute cholecystitis. The presence of a low-echoic area with an irregular multiple structure showing 62 % sensitivity (95 % CI 35.1–88.0) and 100 % specificity (95 % CI 100–100) has a higher diagnostic value [32] (Supplement Fig. 1; Supplement Movie 1).

Q8. What findings are to be noted when ultrasonography is conducted for cases for which acute cholecystitis is suspected?
Ultrasonographic Murphy’s sign refers to the pain that occurs when the gallbladder is pressed while it is being depicted with an ultrasonographic probe. It is superior to the ordinary Murphy’s sign in that it is possible to press the gallbladder accurately. On the basis of the examination of 219 cases of right upper quadrant abdominal pain, Ralls et al. have reported that ultrasonographic Murphy’s sign is somewhat inferior to the ordinary Murphy’s sign in sensitivity (63.0 %, 95 % CI 49.1–77.0 %), although it is superior in specificity (93.6 %, 95 % CI 90.0–97.3 %) [33]. According to Bree et al. who examined 200 cases (of which 73 cases were acute cholecystitis) with complaints of right upper quadrant abdominal pain, the sensitivity of ultrasonographic Murphy’s sign is good (86.3 %; 95 % CI 78.4–94.2 %) although the specificity is inferior (35.0 %; 95 % CI 26.4–43.0 %), so the presence of bile stones should be taken into account when a diagnosis is made [34]. Ultrasonographic Murphy’s sign can also be used to distinguish acute cholecystitis from cases of Murphy’s sign positive due to other diseases and for diagnosis of the causative disease, such as duodenal ulcer (Fig. 2).
Fig. 2

US images of perforated duodenal ulcer case with positive Murphy’s sign (non-ultrasonographic), increased white blood cell count and elevated C-reactive protein. Wall thickening of the anterior wall of the duodenal bulb as well as a large wall defect accompanied with extramural air is clearly demonstrated by US

Q9. Is color or power Doppler imaging useful for making a diagnosis of acute cholecystitis?

Soyer et al. examined 129 cases complaining of acute pain in the upper right quadrant abdomen and reported that the diagnostic capacity for acute cholecystitis on the basis of Doppler sonographic findings were: sensitivity 95 %, specificity 100 %, accuracy 99 %, PPV 100 %, and NPV 99 %, exceeding that of the B-mode Doppler sonography (sensitivity 86 %, specificity 99 %, accuracy 92 %, PPV 92 %, and NPV 87 %) [35] (Supplement Table 2).

On the other hand, Tessler et al. [36] who examined a small number of cases have found that intramural Doppler signals are also observed in normal cases and that signal depiction becomes more remarkable after food intake. Furthermore, Jeffrey et al. carried out detailed discussion of 54 cases undergoing surgery for cholecystitis and 115 normal controls including the area of depiction and have found that the presence or absence of signal depiction alone is not a finding specific to cholecystitis. They looked at the presence of a blood flow signal extending over more than half of the anterior wall (26 % occurrence rate compared with 2 % for normal cases), and discovered that the signal depicted on the bottom is a more specific finding (the frequency of occurrence being 0 % for normal cases and 19 % for cholecystitis cases) [37].

On the basis of the above observations, it may be possible to make a diagnosis of cholecystitis by means of color or power Doppler sonography. However, the detective capacity of Doppler signals is influenced by the performance and settings of the instruments used and, and the physique of subjects. Careful judgment should be made when using Doppler sonographic findings as the only reference findings including B-mode findings (Supplement Fig. 2).

CT

Q10. What are the characteristic contrast enhanced CT findings of acute cholecystitis?
CT findings of acute cholecystitis were reported as: GB distention (41 %), gallbladder wall thickening (59 %), pericholecystic fat density (52 %), pericholecystic fluid collection (31 %), subserosal edema (31 %), and high-attenuation gallbladder bile (24 %) (Fig. 3; Supplement Fig. 3) [38].
Fig. 3

Acute cholecystolithiasis (62-year-old male). Non-contrast CT (a) shows gallbladder distention, wall thickening, and gallstone (arrow). The arterial phase of contrast-enhanced dynamic CT (b, c, f) shows gallbladder wall edema (asterisk) and focal hepatic enhancement adjacent to the gallbladder (arrowheads). Hepatic enhancement disappears on the equilibrium phase of CT (d, e)

Anatomically, a part of the cholecystic vein directly drains into the liver parenchyma surrounding the gallbladder fossa. In patients with acute cholecystitis, venous blood flow from the gallbladder wall into the liver increases. So, the arterial phase of dynamic CT shows transient focal enhancement of the liver adjacent to the inflamed gallbladder (Fig. 3; Supplement Fig. 3) [39, 40, 41, 42]. This enhancement disappears during the portal and equilibrium phase.

In mild acute cholecystitis, gallbladder distention without wall thickening or edema are the only signs on CT. Because gallbladder size is variable depending on the individual, gallbladder distention is difficult to evaluate on diagnostic imaging (such as ultrasonography or non-contrast CT) of acute cholecystitis. Dynamic CT, especially during the arterial phase, is very useful in mild cholecystitis because of the high sensitivity of transient focal enhancement of the liver adjacent to the gallbladder [41].

Tc-HIDA scans

Hepatobiliary scintigraphy involves intravenous injection of technetium-labeled analogues of iminodiacetic acid, which are excreted into the bile. The failure of the gallbladder to fill within 60 min after administration of the tracer indicates that the cystic duct is obstructed and has a sensitivity of 80–90 % for acute cholecystitis. The false positive rate of 10–20 % is largely explained by cystic duct obstruction induced by chronic inflammation, although in some cases normal gallbladders do not fill due to insufficient resistance at the sphincter of Oddi. When the cystic duct is patent (i.e., no cholecystitis), the gallbladder is normally visualized within 30 min. The “rim sign” is a blush of increased pericholecystic radioactivity, which is present in about 30 % of patients with acute cholecystitis and in about 60 % with acute gangrenous cholecystitis [1]. In patients with suspected acute cholecystitis, hepatobiliary scintigraphy has significantly higher specificity [27] and higher accuracy [43] than ultrasonography. Nevertheless, ultrasonography is usually preferred as the first test because of its immediate availability, easy access, a lack of interference by elevated serum bilirubin levels (since cholestasis interferes with biliary excretion of the agents used for scintigraphy), the absence of ionizing radiation, and the ability to provide information regarding the presence of stones [1].

Severity assessment criteria for acute cholecystitis; TG13

Background

Patients with acute cholecystitis may present a spectrum of disease stages ranging from a mild, self-limited illness to a fulminant and potentially life-threatening disease. In fact, the overall mortality rate of acute cholecystitis is approximately 0.6 % [11, 12]. There were no severity assessment criteria for this common disease until 2007 [16].

TG07 severity assessment criteria for acute cholecystitis

The severity assessment criteria were first presented throughout the world in TG07 [5], where the severity grading of acute cholecystitis was classified into the following 3 categories: “mild (Grade I)”, “moderate (Grade II)” and “severe (Grade III)”. Severe (Grade III) acute cholecystitis was defined as acute cholecystitis associated with organ dysfunction.

Moderate (Grade II) acute cholecystitis was defined as acute cholecystitis in which the degree of acute inflammation is likely to be associated with increased operative difficulty in performing cholecystectomy [44, 45, 46, 47, 48, 49].

Mild (Grade I) acute cholecystitis was defined as occurring in a patient who has no findings of organ dysfunction and mild disease in the gallbladder, enabling cholecystectomy as a safe and low risk procedure. These patients do not have a severity index that meets the criteria for “moderate (Grade II)” and “severe (Grade III)” acute cholecystitis in TG07.

There are reports that discussed and appraised the TG07 severity assessment criteria. According to those papers, the distribution varies as follows: 39.3–68.5 % of the cases were classified as Grade I, 25.5–59.5 % as Grade II, and 1.2–6 % as Grade III [14, 15]. In addition, there is a report suggesting that the assessment criteria have contributed to a decrease in the period of hospital stay [13]. This demonstrates that TG07 severity assessment criteria have received good appraisal; there has so far been no treatise or report that has pointed out matters to be improved and weak points of TG07.

Revision of severity grading for acute cholecystitis; TG07

There are reports on poor prognostic factors of acute cholecystitis and those enabling the estimation of emergency surgery. Factors reported after 2000 include leukocytosis [13, 15, 50, 51, 52, 53, 54, 55], ALP [50, 56, 57], old age [53, 54, 58], diabetes [51, 52], male sex [51, 53], and admission delay [55]. There are also reports of imaging findings such as ultrasonographic findings of gallbladder wall thickening [53] and common bile duct distention [57]. To date there has been a small number of new reports of AST, ALT, LDH, BUN, and creatinine. The severity assessment criteria were reconsidered by the Tokyo Guidelines Revision Committee with new information, evidence, and evaluations of TG07. Consequently, the TG07 severity assessment criteria did not have significant problems that required major revision of the definitions or structures [16]. However, minor changes were made to the description of Grade III severity: dopamine and norepinephrine were both considered as evidence of cardiovascular dysfunction consistent with the SOFA scoring system [59].

TG13 severity assessment criteria for acute cholecystitis

The revised severity grading for acute cholecystitis is shown in Table 4.
Table 4

TG13 severity grading for acute cholecystitis

Grade III (severe) acute cholecystitis

 Associated with dysfunction of any one of the following organs/systems:

 1. Cardiovascular dysfunction

Hypotension requiring treatment with dopamine ≥5 μg/kg per min, or any dose of norepinephrine

 2. Neurological dysfunction

Decreased level of consciousness

 3. Respiratory dysfunction

PaO2/FiO2 ratio <300

 4. Renal dysfunction

Oliguria, creatinine >2.0 mg/dl

 5. Hepatic dysfunction

PT-INR >1.5

 6. Hematological dysfunction

Platelet count <100,000/mm3

Grade II (moderate) acute cholecystitis

 Associated with any one of the following conditions:

 1. Elevated white blood cell count (>18,000/mm3)

 2. Palpable tender mass in the right upper abdominal quadrant

 3. Duration of complaints >72 h

 4. Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis)

Grade I (mild) acute cholecystitis

 Does not meet the criteria of “Grade III” or “Grade II” acute cholecystitis. Grade I can also be defined as acute cholecystitis in a healthy patient with no organ dysfunction and mild inflammatory changes in the gallbladder, making cholecystectomy a safe and low-risk operative procedure

TG07 severity assessment criteria have been adopted in TG13 with minor changes [16].

Q11. What morbid conditions are referred to as severe in assessing severity for acute cholecystitis?

Acute cholecystitis has a better outcome/prognosis than acute cholangitis but requires prompt treatment when gangrenous cholecystitis, emphysematous cholecystitis, or torsion of the gallbladder are present. The progression of acute cholecystitis from the mild/moderate to the severe form means the development of multiple organ dysfunction syndrome (MODS). Organ dysfunction scores, such as Marshall’s multiple organ dysfunction (MOD) score and the sequential organ failure assessment (SOFA) score [60], are sometimes used to evaluate organ dysfunction in critically ill patients. The six factors involved in organ dysfunction have therefore been adopted in TG07 as factors that enable severity assessment.

Q12. What morbid conditions are referred to as moderate in assessing severity for acute cholecystitis?
Q13. In making a diagnosis of acute cholecystitis, what are the factors that enable the assessment of moderate cases?

TG07 included findings such as an elevated level of WBC and imaging findings in assessment items specifically applied in moderate (Grade II) acute cholecystitis. Included in these items is evidence such as leukocytosis (>18,000 mm3) detected at the time of hospitalization, prognostic factors that contribute to the change of surgical techniques from laparoscopic surgery to open surgery, and the time of symptom persistence (of more than 72 h) from the onset of symptoms [44, 61]. The criteria for Grade II (moderate) acute cholecystitis can be defined as acute cholecystitis associated with local inflammatory conditions that make cholecystectomy difficult.

As for the factor “old age”, the following statement had been adopted to call attention in TG07; however the statement is useful for the revised edition, too. “Elderly” per se is not a criterion for severity itself but indicates a propensity to progress to the severe form, and thus is not included in the criteria for severity assessment [5].

When acute cholecystitis is accompanied by acute cholangitis, the criteria for the severity assessment of acute cholangitis should also be taken into account [62, 63].

Q14. What are the findings to be noted when the assessment of gangrenous cholecystitis and emphysematous cholecystitis is carried out by means of ultrasonography?
Through the discussion of 19 cases of gangrenous cholecystitis, Jeffrey et al. [7] found that the membraneous structure of the lumen within the gallbladder is observed in 31.6 % (6 cases), irregular thickening of the gallbladder wall in 47.4 % (9 cases), both of these findings in 21.1 % (4 cases), and either of these findings in 57.9 % (11 cases). Regarding perforation, Forsberg et al. [64] also reported on the basis of the discussion involving 24 cases of perforation and 21 cases of acute cholecystitis without perforation that no specific findings were observed, although a slightly thickened wall was observed (3–20 mm, mean 7 mm, for cases with perforation; 2–13 mm, mean 5.3 mm, for cases without perforation). On the other hand, according to Sood et al. [65] depiction of the ruptured wall as a direct finding of gallbladder perforation was able to be made with ultrasonography in 70 % (16 of 23 cases) and with CT in 78 % (14 of 18 cases). Depending on the performance of the instrument used, it can be assumed that the diagnosis can be made for considerable numbers of cases (Fig. 4; Supplement Movie 2).
Fig. 4

Emphysematous cholecystitis. The presence of intramural/intraluminal gas indicates emphysematous cholecystitis. The echo from small gas bubbles shows multiple reverberation

Notes

Acknowledgments

We would like to express our deep gratitude to the Japanese Society for Abdominal Emergency Medicine, the Japan Biliary Association, Japan Society for Surgical Infection, and the Japanese Society of Hepato-Biliary-Pancreatic Surgery, which provided us with great support and guidance in the preparation of the Guidelines.

Conflict of interest

None.

Supplementary material

534_2012_568_MOESM1_ESM.pdf (13 kb)
Supplement Table 1 (PDF 13 kb)
534_2012_568_MOESM2_ESM.pdf (64 kb)
Supplement Fig. 1 (PDF 64 kb)
534_2012_568_MOESM3_ESM.pdf (13 kb)
Supplement Table 2 (PDF 13 kb)
534_2012_568_MOESM4_ESM.pdf (581 kb)
Supplement Fig. 2 (PDF 582 kb)
534_2012_568_MOESM5_ESM.pdf (544 kb)
Supplement Fig. 3. (PDF 544 kb)

Supplementary Movie 1 (MPG 2971 kb)

Supplementary Movie 2 (MPG 11217 kb)

References

  1. 1.
    Steven M, Strasberg MD. Acute calculous cholecystitis. N Engl J Med. 2008;358:2804–11.CrossRefGoogle Scholar
  2. 2.
    Eskelinen M, Ikonen J, Lipponen P. Diagnostic approaches in acute cholecystitis; a prospective study of 1333 patients with acute abdominal pain. Theor Surg. 1993;8:15–20.Google Scholar
  3. 3.
    Halasz NA. Counterfeit cholecystitis, a common diagnostic dilemma. Am J Surg. 1975;130:189–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Johnson H Jr, Cooper B. The value of HIDA scans in the initial evaluation of patients for cholecystitis. J Natl Med Assoc. 1995;87:27–32.PubMedGoogle Scholar
  5. 5.
    Hirota M, Takada T, Kawarada Y, Nimura Y, Miura F, Hirata K, et al. Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):78–82 (Epub 2007 Jan 30) (clinical practice guidelines: CPGs).Google Scholar
  6. 6.
    Yokoe M, Takada T, Mayumi T, Yoshida M, Hasegawa H, Norimizu S, et al. Accuracy of the Tokyo Guidelines for the diagnosis of acute cholangitis and cholecystitis taking into consideration the clinical practice pattern in Japan. J Hepatobiliary Pancreat Sci. 2011;18:250–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Jeffrey RB, Laing FC, Wong W, Callen PW. Gangrenous cholecystitis: diagnosis by ultrasound. Radiology. 1983;148:219–21.PubMedGoogle Scholar
  8. 8.
    Gruber PJ, Silverman RA, Gottesfeld S, Flaster E. Presence of fever and leukocytosis in acute cholecystitis. Ann Emerg Med. 1996;28:273–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Ryu JK, Ryu KH, Kim KH. Clinical features of acute acalculous cholecystitis. J Clin Gastroenterol. 2003;36:166–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Barie PS, Eachempati SR. Acute acalculous cholecystitis. Curr Gastroenterol Rep. 2003;5:302–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;15(368):230–9.CrossRefGoogle Scholar
  12. 12.
    Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7:132–40.PubMedCrossRefGoogle Scholar
  13. 13.
    Lee SW, Yang SS, Chang CS, Yeh HJ. Impact of the Tokyo guidelines on the management of patients with acute calculous cholecystitis. J Gastroenterol Hepatol. 2009;24(12):1857–1861.Google Scholar
  14. 14.
    Asai K, Watanabe M, Kusachi S, Tanaka H, Matsukiyo H, Osawa A, et al. Bacteriological analysis of bile in acute cholecystitis according to the Tokyo guidelines. J Hepatobiliary Pancreat Sci. 2012;19(4):476–486.Google Scholar
  15. 15.
    Lee SW, Chang CS, Lee TY, Tung CF, Peng YC. The role of the Tokyo guidelines in the diagnosis of acute calculous cholecystitis. J Hepatobiliary Pancreat Sci. 2010;17(6):879–884.Google Scholar
  16. 16.
    Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo guidelines. J Hepatobiliary Pancreat Sci. 2012;19:578–85.PubMedCrossRefGoogle Scholar
  17. 17.
    Murphy JB. The diagnosis of gall-stones. Am Med News. 1903;82:825–33.Google Scholar
  18. 18.
    Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have acute cholecystitis? JAMA. 2003;289:80–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Brewer BJ, Golden GT, Hitch DC, Rudolf LE, Wangensteen SL. Abdominal pain. An analysis of 1,000 consecutive cases in a University Hospital emergency room. Am J Surg. 1976;131:219–23.PubMedCrossRefGoogle Scholar
  20. 20.
    Schofied PF, Hulton NR, Baildam AD. Is it acute cholecystitis? Ann R Coll Surg Engl. 1986;68:14–6.Google Scholar
  21. 21.
    Staniland JR, Ditchburn J, De Dombal FT. Clinical presentation of acute abdomen: study of 600 patients. Br Med J. 1972;3:393–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Singer AJ, McCracken G, Henry MC, Thode HC Jr, Cabahug CJ. Correlation among clinical, laboratory, and hepatobiliary scanning findings in patients with suspected acute cholecystitis. Ann Emerg Med. 1996;28:267–72.PubMedCrossRefGoogle Scholar
  23. 23.
    Adedeji OA, McAdam WA. Murphy’s sign, acute cholecystitis and elderly people. J R Coll Surg Edinb. 1996;41:88–9.PubMedGoogle Scholar
  24. 24.
    Juvonen T, Kiviniemi H, Niemela O, Kairaluoma MI. Diagnostic accuracy of ultrasonography and C reactive protein concentration in acute cholecystitis: a prospective clinical study. Eur J Surg. 1992;158:365–9.PubMedGoogle Scholar
  25. 25.
    Rosen CL, Brown DF, Chang Y, Moore C, Averill NJ, Arkoff LJ, et al. Ultrasonography by emergency physicians in patients with suspected cholecystitis. Am J Emerg Med. 2001;19:32–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Kendall JL, Shimp RJ. Performance and interpretation of focused right upper quadrant ultrasound by emergency. J Emerg Med. 2001;21:7–13.PubMedCrossRefGoogle Scholar
  27. 27.
    Chatziioannou SN, Moore WH, Ford PV, Dhekne RD. Hepatobiliary scintigraphy is superior to abdominal ultrasonography in suspected acute cholecystitis. Surgery. 2000;127:609–13.PubMedCrossRefGoogle Scholar
  28. 28.
    Shea JA, Berlin JA, Escarce JJ, Clarke JR, Kinosian BP, Cabana MD, et al. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med. 1994;154:2573–81.PubMedCrossRefGoogle Scholar
  29. 29.
    Ralls PW, Coletti PM, Lapin SA, Chandrasoma P, Boswell WD, Ngo C, et al. Real-time sonography in suspected acute cholecystitis. Radiology. 1985;155:767–71.PubMedGoogle Scholar
  30. 30.
    Martinez A, Bona X, Velasco M, Martin J. Diagnostic accuracy of ultrasound in acute cholecystitis. Gastrointest Radiol. 1986;11:334–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Park MS, Yu JS, Kim YH, Kim MJ, Kim JH, Lee S, et al. Acute cholecystitis: comparison of MR cholangiography and US. Radiology. 1998;209:781–5.PubMedGoogle Scholar
  32. 32.
    Cohan RH, Mahony BS, Bowie JD, Cooper C, Baker ME, Illescas FF. Striated intramural gallbladder lucencies on US studies: predictors of acute cholecystitis. Radiology. 1987;164:31–5.PubMedGoogle Scholar
  33. 33.
    Ralls PW, Halls J, Lapin SA, Quinn MF, Morris UL, Boswell W. Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis. J Clin Ultrasound. 1982;10:113–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Bree RL. Further observations on the usefulness of the sonographic Murphy sign in the evaluation of suspected acute cholecystitis. J Clin Ultrasound. 1995;23:169–72.PubMedCrossRefGoogle Scholar
  35. 35.
    Soyer P, Brouland JP, Boudiaf M, Kardache M, Pelage JP, Panis Y, et al. Color velocity imaging and power Doppler sonography of the gallbladder wall: a new look at sonographic diagnosis of acute cholecystitis. AJR. 1998;171:183–8.PubMedGoogle Scholar
  36. 36.
    Tessler FN, Tublin ME. Blood flow in healthy gallbladder walls on color and power Doppler sonography: effect of wall thickness and gallbladder volume. AJR. 1999;173:1247–9.PubMedGoogle Scholar
  37. 37.
    Jeffrey RB Jr, Nino-Murcia M, Ralls PW, Jain KA, Davidson HC. Color Doppler sonography of the cystic artery: comparison of normal controls and patients with acute cholecystitis. J Ultrasound Med. 1995;14:33–6.PubMedGoogle Scholar
  38. 38.
    Fidler J, Paulson EK, Layfield L. CT evaluation of acute cholecystitis: findings and usefulness in diagnosis. AJR. 1996;166:1085–8.PubMedGoogle Scholar
  39. 39.
    Yamashita K, Jin MJ, Hirose Y, Morikawa M, Sumioka H, Itoh K, et al. CT finding of transient focal increased attenuation of the liver adjacent to the gallbladder in acute cholecystitis. AJR. 1995;164:343–6.PubMedGoogle Scholar
  40. 40.
    Ito K, Awaya H, Mitchell DG, Honjo K, Fujita T, Uchisako H, et al. Gallbladder disease: appearance of associated transient increases attenuation in the liver at biphasic, contrast enhanced dynamic CT. Radiology. 1997;204:723–8.PubMedGoogle Scholar
  41. 41.
    Kim YK, Kwak HS, Kim CS, Han YM, Jeong TO, Kim IH, et al. CT findings of mild forms or early manifestations of acute cholecystitis. Clin Imaging. 2009;33(4):274–80.PubMedCrossRefGoogle Scholar
  42. 42.
    Singh AK, Sagar P. Gangrenous cholecystitis: prediction with CT imaging. Abdom Imaging. 2005;30(2):218–21.PubMedCrossRefGoogle Scholar
  43. 43.
    Freitas JE, Mirkes SH, Fink-Bennett DM, Bree RL. Suspected acute cholecystitis: comparison of hepatobiliary scintigraphy versus ultrasonography. Clin Nucl Med. 1982;7:364–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Brodsky A, Matter I, Sabo E, Cohen A, Abrahamson J, Eldar S. Laparoscopic cholecystectomy for acute cholecystitis: can the need for conversion and the probability of complications be predicted? A prospective study. Surg Endosc. 2000;14:755–60.PubMedCrossRefGoogle Scholar
  45. 45.
    Teixeira JP, Sraiva AC, Cabral AC, Barros H, Reis JR, Teixeira A. Conversion factors in laparoscopic cholecystectomy for acute cholecystitis. Hepatogastroenterology. 2000;47:626–30.PubMedGoogle Scholar
  46. 46.
    Halachmi S, DiCastro N, Matter I, Cohen A, Sabo E, Mogilner JG, et al. Laparoscopic cholecystectomy for acute cholecystitis: how do fever and leucocytosis relate to conversion and complications? Eur J Surg. 2000;166:136–40.PubMedCrossRefGoogle Scholar
  47. 47.
    Rattner DW, Ferguson C, Warshaw AL. Factors associated with successful laparoscopic cholecystectomy for acute cholecystitis. Ann Surg. 1993;217:233–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Araujo-Teixeria JP, Rocha-Reis J, Costa-Cabral A, Barros H, Saraiva AC, Araujo-Teixeira AM. Laparoscopic versus open cholecystectomy for cholecystitis (200 cases). Comparison of results and predictive factors for conversion. Chirurgie. 1999;124:529–35 (in French with English abstract).Google Scholar
  49. 49.
    Merriam LT, Kanaan SA, Dawes JG, Angelos P, Prystowsky JB, Rege RV, et al. Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy. Surgery. 1999;126:680–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Nguyen L, Fagan SP, Lee TC, Aoki N, Itani KM, Berger DH, et al. Use of a predictive equation for diagnosis of acute gangrenous cholecystitis. Am J Surg. 2004;188(5):463–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Fagan SP, Awad SS, Rahwan K, Hira K, Aoki N, Itani KM, et al. Prognostic factors for the development of gangrenous cholecystitis. Am J Surg. 2003;186(5):481–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Aydin C, Altaca G, Berber I, Tekin K, Kara M, Titiz I. Prognostic parameters for the prediction of acute gangrenous cholecystitis. J Hepatobiliary Pancreat Surg. 2006;13(2):155–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Yacoub WN, Petrosyan M, Sehgal I, Ma Y, Chandrasoma P, Mason RJ. Prediction of patients with acute cholecystitis requiring emergent cholecystectomy: a simple score. Gastroenterol Res Pract. 2010;2010:901739 (Epub 2010 Jun 8).Google Scholar
  54. 54.
    Wang AJ, Wang TE, Lin CC, Lin SC, Shih SC. Clinical predictors of severe gallbladder complications in acute acalculous cholecystitis. World J Gastroenterol. 2003;9(12):2821–3.PubMedGoogle Scholar
  55. 55.
    Contini S, Corradi D, Busi N, Alessandri L, Pezzarossa A, Scarpignato C. Can gangrenous cholecystitis be prevented? A plea against a “wait and see” attitude. J Clin Gastroenterol. 2004;38(8):710–6.PubMedCrossRefGoogle Scholar
  56. 56.
    McChesney JA, Northup PG, Bickston SJ. Acute acalculous cholecystitis associated with systemic sepsis and visceral arterial hypoperfusion: a case series and review of pathophysiology. Dig Dis Sci. 2003;48(10):1960–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Young AL, Cockbain AJ, White AW, Hood A, Menon KV, Toogood GJ. Index admission laparoscopic cholecystectomy for patients with acute biliary symptoms: results from a specialist centre. HPB (Oxford). 2010;12(4):270–6.Google Scholar
  58. 58.
    Girgin S, Gedik E, Taçyildiz IH, Akgün Y, Baç B, Uysal E. Factors affecting morbidity and mortality in gangrenous cholecystitis. Acta Chir Belg. 2006;106(5):545–549.Google Scholar
  59. 59.
    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, International Surviving Sepsis Campaign Guidelines Committee, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296–327.PubMedCrossRefGoogle Scholar
  60. 60.
    Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.PubMedCrossRefGoogle Scholar
  61. 61.
    Hadad SM, Vaidya JS, Baker L, Koh HC, Heron TP, Hussain K, et al. Delay from symptom onset increases the conversion rate in laparoscopic cholecystectomy for acute cholecystitis. World J Surg. 2007;31:1298–301.PubMedCrossRefGoogle Scholar
  62. 62.
    Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, et al. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo guidelines. J Hepatobiliary Pancreat Sci. 2012;19:548–56.PubMedCrossRefGoogle Scholar
  63. 63.
    Tsuyuguchi T, Sugiyama H, Sakai Y, Nishikawa T, Yokosuka O, Mayumi T, et al. Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19:557–65.PubMedCrossRefGoogle Scholar
  64. 64.
    Forsberg L, Andersson R, Hederstrom E, Tranberg KG. Ultrasonography and gallbladder perforation in acute cholecystitis. Acta Radiol. 1988;29:203–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Sood BP, Kalra N, Gupta S, Sidhu R, Gulati M, Khandelwal N, Suri S. Role of sonography in the diagnosis of gallbladder perforation. J Clin Ultrasound. 2002;30:270–4.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Hepato-Biliary-Pancreatic Surgery and Springer 2012

Authors and Affiliations

  • Masamichi Yokoe
    • 1
    Email author
  • Tadahiro Takada
    • 2
  • Steven M. Strasberg
    • 3
  • Joseph S. Solomkin
    • 4
  • Toshihiko Mayumi
    • 5
  • Harumi Gomi
    • 6
  • Henry A. Pitt
    • 7
  • O. James Garden
    • 8
  • Seiki Kiriyama
    • 9
  • Jiro Hata
    • 10
  • Toshifumi Gabata
    • 11
  • Masahiro Yoshida
    • 12
  • Fumihiko Miura
    • 2
  • Kohji Okamoto
    • 13
  • Toshio Tsuyuguchi
    • 14
  • Takao Itoi
    • 15
  • Yuichi Yamashita
    • 16
  • Christos Dervenis
    • 17
  • Angus C. W. Chan
    • 18
  • Wan-Yee Lau
    • 19
  • Avinash N. Supe
    • 20
  • Giulio Belli
    • 21
  • Serafin C. Hilvano
    • 22
  • Kui-Hin Liau
    • 23
  • Myung-Hwan Kim
    • 24
  • Sun-Whe Kim
    • 25
  • Chen-Guo Ker
    • 26
  1. 1.General Internal Medicine, Nagoya Daini Red Cross HospitalNagoyaJapan
  2. 2.Department of SurgeryTeikyo University School of MedicineTokyoJapan
  3. 3.Section of Hepatobiliary and Pancreatic SurgeryWashington University in Saint Louis School of MedicineSaint LouisUSA
  4. 4.Department of SurgeryUniversity of Cincinnati College of MedicineCincinnatiUSA
  5. 5.Department of Emergency and Critical Care MedicineIchinomiya Municipal HospitalIchinomiyaJapan
  6. 6.Center for Clinical Infectious Diseases, Jichi Medical UniversityTochigiJapan
  7. 7.Department of SurgeryIndiana University School of MedicineIndianapolisUSA
  8. 8.Clinical SurgeryThe University of EdinburghEdinburghUK
  9. 9.Department of GastroenterologyOgaki Municipal HospitalOgakiJapan
  10. 10.Department of Endoscopy and UltrasoundKawasaki Medical SchoolOkayamaJapan
  11. 11.Department of RadiologyKanazawa University Graduate School of Medical ScienceKanazawaJapan
  12. 12.Clinical Research Center Kaken HospitalInternational University of Health and WelfareIchikawaJapan
  13. 13.Department of SurgeryKitakyushu Municipal Yahata HospitalKitakyushuJapan
  14. 14.Department of Medicine and Clinical OncologyGraduate School of Medicine Chiba UniversityChibaJapan
  15. 15.Department of Gastroenterology and HepatologyTokyo Medical UniversityTokyoJapan
  16. 16.Department of Gastroenterological SurgeryFukuoka University School of MedicineFukuokaJapan
  17. 17.First Department of SurgeryAgia Olga HospitalAthensGreece
  18. 18.Department of Surgery, Surgery CentreHong Kong Sanatorium and HospitalHong KongHong Kong
  19. 19.Faculty of MedicineThe Chinese University of Hong KongHong KongHong Kong
  20. 20.Department of Surgical GastroenterologySeth G S Medical College and K E M HospitalMumbaiIndia
  21. 21.General and HPB Surgery, Loreto Nuovo HospitalNaplesItaly
  22. 22.Department of SurgeryCollege of Medicine-Philippine General Hospital, University of the PhilippinesManilaPhilippines
  23. 23.Hepatobiliary and Pancreatic Surgery, Nexus Surgical Associates, Mount Elizabeth HospitalSingaporeSingapore
  24. 24.Department of Internal Medicine, Asan Medical CenterUniversity of UlsanSeoulKorea
  25. 25.Department of SurgerySeoul National University College of MedicineSeoulKorea
  26. 26.Yuan’s General HospitalKaohsiungTaiwan

Personalised recommendations